| abstract |
[Summary] Particularly for use in a plurality of S. aureus vaccines. To identify further improved antigens for vaccines useful against aureus pathology. SOLUTION: S. Various combinations of aureus antigens are identified for use in immunization. These polypeptides can be purified by S. coli, if desired. It may be used in combination with an aureus saccharide. We have the following 36 polypeptides: clfA, clfB, coA, eap, ebhA, ebpS, efb, emp, esaC, esxA, esxB, FnBA, FnBB, Hla, hlgB, hlgC, isdA, isdB, isdC, isdG, isdH, isdI, lukD, lukE, lukF, lukS, nuc, sasA, sasB, sasC, sasD, sasF, sdrC, sdrD, spa, and sdrE2. [Selection figure] None |